Call Options Transactions Made in Q2 2024 in I Teos Therapeutics, Inc. (ITOS)
This table provides information about the institutional ownership of I Teos Therapeutics, Inc. (ITOS) during Q2 2024. The information is specifically focused on institutions that hold call options of iTeos Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
K2 Principal Fund, L.P.
Toronto, A6 |
BUY
|
CALL |
419K+ 1333.12% |
$4.32M - $7.57M
|
450K
$3.6M
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
154K+ 619.76% |
$1.59M - $2.78M
|
179K
$1.43M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
10.8K+ 82.44% |
$112K - $195K
|
23.9K
$191K
|
|
Aug 09, 2024
Q2 2024
|
Belvedere Trading LLC
|
BUY
|
CALL |
100New |
$1.03K - $1.81K
|
100
$800
|
|
Nov 01, 2024
Q2 2024
|
Belvedere Trading LLC
|
SELL
|
CALL |
-100- 50.0% |
$1.03K - $1.81K
|
100
$800
|